Core Scientific Inc. is the subject of a proposed sale to CoreWeave, Inc., as announced on July 7, 2025. The transaction has drawn attention from major shareholders, with Two Seas Capital LP, the largest active shareholder of Core Scientific, publicly opposing the deal. Two Seas Capital released an investor presentation highlighting concerns about the transaction process, deal structure, and valuation, noting that Core Scientific's stock performance has lagged behind its peers since the announcement. The presentation argues that the proposed terms undervalue Core Scientific and ties its future to what is described as CoreWeave's underperforming stock.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Core Scientific Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NE95908) on October 13, 2025, and is solely responsible for the information contained therein.